Image Alt

January 2024

  -  News   -  January 2024

January 2024

The photography prize & the Escourbiac – Fondation des Treilles prize

For its 13th edition, the photo jury, chaired by Jean-Luc Monterosso, will meet at the end of January to study the candidates’ applications and designate the 2024 winners of the Photography Prize and the Escourbiac – Fondation des Treilles Prize. Each year a winner is invited to participate in the deliberations. In 2024, we will have the pleasure of reuniting with Corinne Mercadier, who won the prize in 2018. This year the jury will pay tribute to one of its members, Bernard Perrine, who died at the end of 2023.

The Musical Composition Prize

In 2024 we will welcome Harold Noben to the Treilles estate. Harold Noben is a Belgian composer based in Brussels. After obtaining his advanced piano diploma at the Royal Conservatory of Music in Liège, his hometown, he gradually devoted himself to composition.

His first opera, “At the Extreme Edge of the World”, a chamber opera dealing with the tragic end of Stefan Zweig and his second wife Lotte, premiered at La Monnaie, Brussels, in October 2020. He receives commissions from various ensembles and orchestras including, among others, the Queen Elisabeth Music Chapel, La Monnaie, the Royal Philharmonic Orchestra of Liège, the Ô-Celli cello octet, the Musiques Nouvelles ensemble…

His string quartet “Quartet from the Portuguese” based on the work of the poet Elisabeth Barrett Browning Sonnets from the Portuguese, received the Marcel Hastir Prize from the Royal Academy of Belgium in November 2022. During the Residency at the Fondation des Treilles, Harold Noben will focus all his work on the creation of his new opera for voice, orchestra and small choir. The subject of this one is an adaptation of Madame Bovary, Gustave Flaubert’s masterpiece, the libretto of which is produced by the author and director Michaël De Cock. [Learn more] 

The Treilles meetings

On the occasion of the nuits de la lecture 2024 (2024 Reading Nights), the foundation is pleased to organize a meeting with its laureates around the reading of texts selected by the authors around the theme of the “body”, followed by an exchange with the audience.

Meeting with the winners of the Fondation des Treilles “Author Residency” Prize.

In partnership with the bookstore “Les Guetteurs de Vent”, 108 Avenue Parmentier, 75 011 Paris.

In the presence of the authors Dimitri Bortnikov, Garance Meillon and Sami Tchak.

From 7:30 p.m. A cocktail will close the evening. Limited places.

Conference by Maryvonne de Saint Pulgent, president of the Fondation des Treilles

on Saturday, January 20, at 6 p.m. at the Auditorium de la Dracénie in Draguignan (83, Var) on the occasion of the publication of “The glory of Notre Dame: faith and power” (Gallimard, December 2023).

The Treilles blog

Cancer immunotherapy

Cancer immunotherapy revolutionized the treatment of some metastatic solid tumors, starting with the first definitive clinical trial results with melanoma, published in 2011. Following the disruptive effect of therapies blocking CTLA4 and the PD1 pathway, the cancer immunotherapy field settled into a phase of incremental progress. Most patients and many tumor types remain refractory to immunotherapy. With the notable exception of the introduction of CART therapy for lymphoma in the mid 2010s, subsequent progress has been slow and clinical development has sailed close to the shoreline of earlier successes. There are currently about 6,000 clinical trials of drugs targeting the PD-1 pathway, most as combination therapies with pre-existing cancer drugs. New immunomodulatory agents targeting other checkpoint molecules such as LAG3 are trickling into the clinic. But the grand challenges of increasing patient response rates, developing reliable prognostic markers, and, especially, heating up immunologically “cold” tumors remain.

A workshop at Les Treilles, organized by Tasuku Honjo and Antonio Coutinho, seemed ideal to review and discuss the molecular and cellular mechanisms of cancer immunotherapy, such that the reasons for its current limitations could perhaps be pinpointed and new opportunities found. [Learn more]